BeStock  
Stocks › ARQT

Arcutis Biotherapeutics ARQT

US equityMarket cap rank #2441
$25.15 −$0.01 (-0.04%)
Pre-market · Oct 6, 7:40 am ET · After hours $25.25 +0.40%
Open$25.09
Prev close$25.16
Day range$24.69 – $25.39
Volume2.31M
Market cap$3.16B
P/E (TTM)114.3
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership107.6%-0.15 pts vs. prior quarter
Institutions holding336+2 vs. prior quarter
Insider trades (recent)18 buys / 31 sellsNet selling
Short interest14.69% of floatDays to cover 8.5 · as of 15 Sep 2026
Short-sale volume share23.9%5-day average of daily volume

Short-sale volume as % of daily volume

15%21%28%34%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$7.99M (12 inflow days, 8 outflow days).

The five largest holders on file together own 38.0% of shares outstanding.

Largest holders

  • Montanova Capital, LLC9.89%
  • BlackRock8.39%
  • Frazier Life Sciences Management, LP7.86%
  • Rubric Capital Management LP6.58%
  • Polar Capital Holdings Plc5.26%
  • State Street Global Advisors4.63%
  • Vanguard Capital Management, LLC4.62%
  • Morgan Stanley3.49%

By investor type

  • Mutual Fund58.37%
  • Hedge Fund26.52%
  • VC/PE Fund10.80%
  • Public Company7.07%
  • Private Company3.41%
  • Individual/Insider1.03%
  • Government Pension Fund0.71%
  • Sovereign Wealth Fund0.32%

Reported short interest has risen from 11.21% to 14.69% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 18,458,091 14.7% 8.5
31 Aug 2026 16,557,048 13.2% 9.4
14 Aug 2026 14,717,905 11.7% 8.0
31 Jul 2026 12,686,384 10.1% 10.7
15 Jul 2026 13,561,565 10.8% 9.3
30 Jun 2026 14,019,289 11.2% 6.3

Discussion

No comments yet — be the first to weigh in on ARQT.

Leave a comment

Scroll to Top